Stocks and Investing
Stocks and Investing
Tue, December 6, 2022
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
[ Tue, Dec 06th 2022
] - WOPRAI
Jay Olson Maintained (AMGN) at Buy with Increased Target to $310 on, Dec 6th, 2022
Jay Olson of Oppenheimer, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $300 to $310 on, Dec 6th, 2022.
Jay has made no other calls on AMGN in the last 4 months.
There are 6 other peers that have a rating on AMGN. Out of the 6 peers that are also analyzing AMGN, 1 agrees with Jay's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gregory Renza of "RBC Capital" Maintained at Hold with Increased Target to $240 on, Friday, November 4th, 2022
These are the ratings of the 5 analyists that currently disagree with Jay
- Trung Huynh of "Credit Suisse" Initiated at Sell and Held Target at $240 on, Friday, November 18th, 2022
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $278 on, Friday, November 4th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $282 on, Friday, November 4th, 2022
- Carter Gould of "Barclays" Downgraded from Hold to Sell and Held Target at $234 on, Monday, October 31st, 2022
- Steve Chesney of "Atlantic Equities" Maintained at Sell with Decreased Target to $182 on, Tuesday, August 9th, 2022
Contributing Sources